MENU
+Compare
SLNCF
Stock ticker: OTC
AS OF
Sep 24 closing price
Price
$1.45
Change
-$0.15 (-9.38%)
Capitalization
205.47M

SLNCF Silence Therapeutics, Plc. Forecast, Technical & Fundamental Analysis

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA... Show more

SLNCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for SLNCF with price predictions
Sep 26, 2025

SLNCF in downward trend: 10-day moving average broke below 50-day moving average on September 04, 2025

The 10-day moving average for SLNCF crossed bearishly below the 50-day moving average on September 04, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 24, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on SLNCF as a result. In of 61 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for SLNCF turned negative on September 24, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at .

SLNCF moved below its 50-day moving average on August 25, 2025 date and that indicates a change from an upward trend to a downward trend.

The Aroon Indicator for SLNCF entered a downward trend on September 26, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 22 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 42 cases where SLNCF's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The 50-day moving average for SLNCF moved above the 200-day moving average on September 10, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.182) is normal, around the industry mean (19.797). P/E Ratio (0.000) is within average values for comparable stocks, (53.778). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.098). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (7.559) is also within normal values, averaging (350.259).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. SLNCF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SLNCF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
SLNCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
72 Hammersmith Road
Phone
+44 2034576900
Employees
109
Web
https://www.silence-therapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CSMAX14.420.15
+1.05%
Calvert Global Small-Cap Equity A
PRACX51.850.28
+0.54%
Putnam Research C
GGGAX64.940.26
+0.40%
Gabelli Global Growth A
IASTX24.660.09
+0.37%
Macquarie Asset Strategy Fund Cl R6
BTEKX83.29-0.07
-0.08%
BlackRock Technology Opportunities K

SLNCF and Stocks

Correlation & Price change

A.I.dvisor tells us that SLNCF and NAMS have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SLNCF and NAMS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLNCF
1D Price
Change %
SLNCF100%
N/A
NAMS - SLNCF
24%
Poorly correlated
+8.44%
SANA - SLNCF
22%
Poorly correlated
-1.47%
QLGN - SLNCF
21%
Poorly correlated
-8.51%
APGE - SLNCF
21%
Poorly correlated
+1.84%
ANIX - SLNCF
20%
Poorly correlated
+0.62%
More